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The matrix extracellular phosphoglycoprotein (MEPE) gene is highly expressed in tumors that cause 
oncogenic hypophosphatemic osteomalacia (OHO). MEPE is also known as one of the bone-tooth 
matrix proteins and is associated with bone and teeth mineralization. We developed a rabbit polyclonal 
antibody directed against recombinant human MEPE after cloning its cDNA from the cDNA library of a 
human brain cDNA library. Using this anti-body, we analyzed the distribution of MEPE in dog dental 
germ tissue by immunohistochemistry. In these specimens, MEPE was predominantly expressed by 
odontoblast cells and predentin, but not by dental pulp cells. Furthermore, we used von kossa staining 
and the results suggested that, MEPE could induce mineralization and we propose that this protein had 
a potential effect on dental rehabilitation. 
 





Recently, a new bone matrix protein cDNA has been 
cloned from human, rat and mouse by independent 
groups (Rowe et al., 2000; Petersen et al., 2000; Argiro et 
al., 2001). The human clone, termed MEPE (matrix 
extracellular phosphoglycoprotein), was isolated from a 
human oncogenic hypophosphatemic osteomalacia 
tumor (OHO) cDNA library (Rowe et al., 2000). MEPE, 
BSP (bone sialoprotein), OPN (osteopontin, but 
sometimes known as SPP1 and Eta-1), DMP I (dentin 
matrix protein I) and DSPP (dentin sialophosphoprotein) 
are the products of five genes clustered along human 
chromosome 4q21 (Rowe et al., 2000; Petersen et al., 
2000; Argiro et al., 2001) between EST markers D4S2785 
(WI-6336) and D4S2844. The majority of each protein is 
encoded by the last one or two exons and contains the 
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these genes is that, all introns always interrupt between 
codons (type 0), thus, leaving open the possibility of 
splicing any two exons together without causing frame 
shifts. We have named this protein family the SIBLING 
family (small integrin-binding ligand n-linked 
glycoprotein). And it is based not on current theories of 
their functions (which are poorly understood), but on the 
simple biochemical and genetic features shared by all 
members. The human MEPE has 1989 bp cDNA clone 
and encodes a predicted 525-amino-acid protein rich in 
Asp, Ser and Glu residues (26%) containing a 17-amino-
acid signal peptide. MEPE contains two N-glycosylation 
motifs (NNST and NNSR), a glycosaminoglycan 
attachment site (SGDG), an RGD cell attachment motif, 
several predicted phosphorylation motifs and N-
myristoylation sites (Rowe et al., 2000).  
In dental tissue, MEPE is expressed in odontoblasts 
during odontogenesis (MacDougall et al., 2002). Liu et al. 
(2004) have found that, dentonin (a 23-amino-acid 
peptide derived from MEPE) could promote DPSC 
proliferation, taking a  potential  role  in  pulp  repair.  That  




study suggestted that, dentonin affects primarily the 
innitial cascade of events leading to pulp healing. 
In this study, we have cloned MEPE cDNA by RT-PCR, 
expressed MEPE in Escherichia coli cells, purified the 
recombinant protein and prepared anti-MEPE antibodies. 
Then western blot and immunohistochemistry were 
applied in the study. Finally, Von kossa staining was used 
to investigate the mineralization ability of MEPE. 
 
 
MATERIALS AND METHODS 
 
MEPE cDNA clone isolation and amplifications 
 
Human MEPE cDNA sequence from human brain cDNA library (BGI 
LifeTech Co., Ltd.) was amplified using reverse transcriptase PCR. 
The cDNA clones were isolated in 50 µl reaction mixture using 
human MEPE primers(1 µl, 1 µmol/l, forward: 5’- 
CGGAATTCACCAGAGATTCTCAAAGATGCGAG -3’with an  EcoRI 
restriction site and 1 µl, 1 µmol/l, reverse: 5’- 
CGAAGCTTGAACTCCTGGTGGACTAGTCACC -3’，with an Hind 
III restriction site), high fidelity platinum Pfx DNA polymerase (0.5 
µl, 1.5 U, Promega), 10×PCR buffer (5 µl), MgCl2 (1.5 µl, 50 
mmol/l), dNTP mix (1 µl, 10 mmol/l, Promega), human brain cDNA 
library (5 µl, denatured 99°C,10 min) and DEPC-treated water (35 
µl).  
PCR amplifications were carried out at 94°C for 5 min, followed 
by 35 cycles of 94°C for 30 s, 54°C for 30 s, 72°C for 90 s and 72°C 
for 10 min for final extension and held at 4°C. Reaction products 
were analyzed by electrophoresis of 10 µl samples in 1% (w/v) 
agarose gels and visualized by ethidium bromide staining under UV 
light. DL-2000 DNA ladder (TaKaRa, Japan) served as size marker.  
 
 
Sequencing and sequence analysis 
 
The PCR products were subcloned into vector pGEM
®
-T and then 
transformed into E. coli DH5α. MEPE DNA was isolated by the 
Sanger dideoxynucleotide chain termination procedure (Sanger et 
al., 1977) using ClearCut Miniprep kit (Stratagene, CA). Sequences 
were read by BGI corp (Takara corp, Japan). Each sequencing 
reaction was performed twice in both directions. Sequencing of 
PCR fragments confirmed the sequence obtained. Sequence 
alignments were performed using the computer program BLAST 
(Altschul et al., 1990; Zhang et al., 1997). Protein sequence 
analysis (PSA) was performed using the PROSITE (Hofmann et al., 
1999) programs.  
 
 
Expression and purification of MEPE proteins 
 
The PCR products were subcloned into vector pGEM
®
-T and 
pGEX-4T-2 and the construct transformed into E. coli BL21 (DE3). 
White clones were then selected on ampicillin plates. The MEPE 
clones were incubated at 37°C over night, and then incubated for a 
further 3 h at 42°C using IPTG. Recombinant MEPE was purified 
using calmodulin affinity chromatography resin as described in the 





Samples were mixed up with the buffer (0.1% bromophenol blue, 
20% glycerin, 2% β-mercaptoethanol, 0.1 mol/l Tris-HCl, pH 8.8 and 





12000 r/min for 10 min, electrophoresis was performed in 1% (w/v) 
agarose gels. Finally, the products were stained with Coomassie 
blue (25% isopropanol, 0.25% Coomassie blue R 250, 5% glacial 
acetic acid) and bands were visualized by dynamic integrated 
exposure using an EagleEye II imaging system (Stratagene Corp., 
La Jolla, CA). 
 
 
Antibody generation and western blot analysis 
 
High titer polyclonal antiserum was generated by immunization of 
rabbits with E. coli expressed full-length MEPE. MEPE antibody 
was affinity-purified by chromatography. MEPE-coupled agarose 
beads by standard methods (Harlow et al., 1988). Protein samples 
were dissolved in SDS gel-loading buffer (Invitrogen Carlsbad, CA, 
USA). Separated proteins were transferred to a nitrocellulose 
membrane (0.45l m, Bio-Rad, Chicago, IL USA) at room 
temperature using semi-dry blotting system (Millipore, Chicago, IL 
USA). Immunoblotting was performed using anti-MEPE antisera 
diluted 1:2000 in TBS and 1% bovine albumin (BSA) for 1h at room 
temperature. The blots were washed in TBS for 60 min and 
incubated with anti-rabbit IgG conjugated with HRP (diluted to 
1:5000) at room temperature for 60 min. After washing in TBS, 
immunoreactivity was detected by ECL detection kit (Amersham 





A mandible specimen from young dog was fixed in 4% 
paraformaldehyde and decalcified in 10% EDTA for 1 h. Bones 
were embedded into paraffin and 5 mm sections were placed onto 
Digene silanated slides (Beltsville, MD) and heated overnight at 
50°C. Slides were rehydrated and endogenous peroxidase activity 
was blocked by incubating sections in 3% H2O2 in methanol for 30 
min at room temperature and then the sections were incubated in 
10% normal goat serum to minimize nonspecific background 
staining. Sections were blocked in 1% BSA/PBS and incubated 
overnight at 4°C in a humidified chamber with the rabbit polyclonal 
antibody diluted at 1:500 in 0.1% BSA/PBS and the rabbit IgG 
(Vector Laboratory Inc., Burlingame CA) as a control. Secondary 
anti-body consisting of anti-rabbit IgG Fab fragments linked to 
horseradish peroxidase (Amersham Pharmacia Biotech) was 
diluted at 1:100 in 0.1% BSA/PBS and placed onto sections for 1 h 
at room temperature. Detection was performed using a 
diaminobenzidene substrate chromagen system according to the 





Human pulp cells were grown from pulp tissue as reported 
previously. Normal human pulp was obtained from extracted 
impacted third molars. These molars were collected from adults (17 
to 25 years old) at stomatology hospital of Fourth Military Medical 
University with patient’s informed consent. The whole procedure 
followed an informed protocol approved by the local ethics 
committee. After extraction, the teeth were washed with saline and 
cut at the apex, followed by the removal of pulp tissue. The isolated 
pulp tissues were minced into 1 mm
3
 pieces and incubated in 
minimal essential medium (MEM (Life Technologies, Inc. Grand 
Island, N.Y.)) supplemented with an antibiotic solution (100 U/ml 
penicillin-G and 200 ug/ml streptomycin, 5 ug/ml amphotericin B) 
and 10% fetal bovine serum (FBS). Cells were grown at standard 
cell culture conditions (37°C, 100% humidity, 95% air and 5% 
carban dioxide) for 20 days and the medium was exchanged at 3 
day intervals. Cells that were released from the minced pulp 
explants  were   harvested   and  further  cultured  to  acquire  sixth- 






Figure 1. Human MEPE fragment was generated by RT-PCR from 
human brian cDNA library: A (lane 1. PCR products, lane 2. 




passage cells which were used in this study. 
 
 
Von kossa staining  
 
Von kossa staining was used to evaluate the formation of 
mineralized nodules on day 15 in 100 µg/ml. Cell cultures were 
rinsed with PBS and fixed in 4% formaldehyde in PBS for 10 min. 
After washing with distilled water, cells were treated with 5% silver 
nitrate solution and kept for 30 min in dark room. The excess silver 
nitrate solution was then completely washed away using distilled 
water and the culture plate was treated with sodium 
carbonate/formaldehyde solution for few minutes to develop color. 
Residual silver nitrate was neutralized with 5% sodium thiosulfate. 
Plates were finally rinsed extensively with water and air-dried. 





Isolation and recombinant of MEPE  
 
In this study, a human MEPE fragment of about 1.5 kb 
was generated by RT-PCR from human brain cDNA 
library (Figure 1). Identity of the PCR product with the 
published human MEPE cDNA sequence was confirmed 
by sequencing. A 1578 bp sequence was obtained. This 
sequence contained a TAG termination codon. No poly 
(A) tail or translation initiation codon was detected. The 
ATG codon at position 40 was selected as the translation 
initiation codon, because it lies in the context of a Kozak 
criterion (Kozak et al., 1996). Gene content mapping was 
then performed using the isolated human MEPE/OF45 
BAC genomic clone. The predicted secreted MEPE 
protein has a calculated molecular mass of 56 kDa. 
 
 
Expression of MEPE proteins and SDS-page 
 
The cDNA coding sequence comprising amino acids 95 
to 525 was subcloned into pGEX-4T-2 as described 
under Materials and Methods. Validation of the fusion 
construct generated by IPTG induction of the E. coli host 
BL21 (DE3) was achieved by SDS-page. The fusion 
protein was 56 kD (Figure 2). This is in approximate 
agreement with the expected molecular size. Purification 
of recombinant protein was achieved by calmodulin 




Western blot analysis and Immunohistochemical 
staining 
 
The specificity of the anti-MEPE antibody was examined 
by the western blotting of E. coli expressing MEPE. When 
the E. coli lysate was tested, MEPE immunoreactivity 
was visualized as a single band at 56 kDa (Figure 3a), 
demonstrating high specificity of the anti-MEPE antibody. 
Figure 3b, c, d, shows MEPE expression in dog dental 
germ tissue. MEPE was expressed by odontoblasts cell and predentin, but it  was  not  expressed  in  dental  pulp  






Figure 2. The fusion construct generated by IPTG induction of the E. coli host 
BL21 (DE3) was achieved. The fusion protein was about 56kD. This is in 
approximate agreement with the expected molecular size. Purification of 
recombinant protein was achieved by calmodulin affinity chromatography as 
described under Materials and Methods. Lane 1, LMW-SDS Marker Kit; lane 2, 
blank vector; lane 3, non-induced E.coli; lane 4, induced E.coli; lane 5, lysate 




cells (Figure 3b).  
 
 
Von kossa staining 
 
MEPE (100 µg/ml) induced HDPCs as assayed using the 
von Kossa stain after 28 days. Von Kossa-positive 
staining was apparent in the control cells with MEPE. The 
results for 0, 7, 14, 28 days shown in Figure 4 show 





MEPE is a protein of the extracellular matrix that was first 
described in tumor-induced osteomalacia where it is 
highly expressed and has recently been characterized as 
a novel bone metabolism regulator. The genomic 
localization of MEPE on human chromosome 4q21 was 
refined in relationship to the previously identified 
dentin/bone gene cluster by gene content mapping. This 
data suggested that the MEPE gene was potentially 
located closer to other family members BSP or SPP1 
(Argiro et al., 2001). Complete MEPE cDNA encodes 525 
amino acid residues and 1989 bp of nucleic acid 
sequence. The predicted secreted MEPE protein has a 
calculated molecular mass of 56 kDa. As reported for 
human MEPE, a specific feature of the MEPE protein is 
the occurrence in the C-terminus of a serine-rich 
sequence, DDSSESSDSGSSSES (residues 417 to 430), 
that displays homology to repeat motifs found in dentin 
phosphoprotein, DPP/DSPP(SDSSDSSDSSSSSDSS), 
DMP1 (SSRRRDDSSESSDSGSSSESDG), osteopontin 
(DDSHQSDESHHSDESD) and the parent protein, dentin 
sialophosphoprotein,. 
However, its function is still poorly understood (Rowe et 
al., 2000; Argiro et al., 2001; MacDougall et al., 2002; 
Gowen et al., 2003; Guo et al., 2002; Quarles et al., 
2003). To better understand the role of MEPE in dental 
formation, repair and remodeling, we isolated and 
characterized the isolation of a cDNA encoding the 
murine homologue of human MEPE and demonstrated its 
expression in E. coli. Then, we purified the recombinant 
protein and studied the effects of MEPE on HA through 
Von kossa staining.  
In this study, a human MEPE mRNA species of 1.5 kb 
was identified from human brain cDNA library 
(MacDougall et al., 2002) which was consistent with the 
reported expression of human MEPE (Rowe et al., 2000). 
Previous in vitro studies have suggested a correlation 
between MEPE expression and bone mineralization. Argiro et al. (2001) reported a correlation between MEPE  






Figure 3. The specificity of the anti-MEPE antibody was examined by the western blotting of E. coli expressing MEPE: A 
(lane 1, 2, induced E.coli; lane 3, culture solution; lane 4, LMW-SDS marker kit). The fusion protein was about 56 kD in 
lane 1, 2. This is in approximate agreement with the expected molecular size; B Immunohistochemical staining shows 
MEPE expression in dog grem tissue; C: MEPE was not expressed in dental pulp cells; D, E MEPE was expressed in 
odontoblasts Cell but it was not expressed in dental pulp cells.  






Figure 4. Von kossa staining. MEPE induced HDPCs as 
assayed using the von Kossa stain after 28 days. Von kossa-
positive staining was apparent in the control cells with MEPE.A, 




expression and bone mineralization after the addition of 
glycerophosphate to osteoblast culture medium. MEPE 
plays a significant role in osteoblast-mediated minera-
lization. These dentin-specific proteins are expressed by 
fully differentiated odontoblasts prior to the onset of 
mineralization (D'Souza et al., 1992; Bronckers et al., 
1993) and are believed to play a role in dentin 
mineralization (Butler et al., 1997). We used an 
immunohistochemical approach and found that MEPE 
protein was expressed in dog dental germ tissures 
especially in odontoblasts cell and predentin. These 
results indicated that, during dentin development, MEPE 
might be involved in the initiation mineralization. 





of bone growth and remodeling. But the expression of 
MEPE by odontoblasts is not surprising, since all the 
other SIBLING members are expressed by both 
odontoblasts and osteoblasts. Bone and dentin are both 
collagenous mineralized extracellular matrices that 
consist of similar ECM proteins.  
The process of formation of mineralized nodules has 
three main developmental stages: Proliferation, 
development of the extracellular matrix and 
mineralization (Chen PS et al., 1956). Some studies with 
a variety of different experimental systems have 
attempted to determine the effects of mineralized tissue 
proteins in vitro. The most exhaustively studied of these 
proteins is DPP. DPP has been shown to inhibit the 
mineralization in solution (Doi et al., 1992), agarose gels 
(Fujisawa et al., 1987) and the growth of HA seed 
crystals (Termine et al., 1980) and the BSP, but not 
osteopontin, is capable of inducing the mineralization. 
Several workers have found growth of mineralization in 
vitro (Fujisawa et al., 1987; Termine et al., 1980; Nawrot 
et al., 1976; Boskey et al., 1990). These investigations 
have yielded contradictory findings, with phosphophoryn 
promoting mineralization formation in some systems and 
inhibiting it in others. It does seem clear that, 
phosphophoryn covalently attached to agarose beads 
acts as a potent nucleator of mineralization formation in 
solutions of low calcium phosphate supersaturation 
(Linde et al., 1989). No studies on the effect of MEPE on 
mineralization formation have been reported. Our 
experiment confirms that, MEPE has strong 
mineralization ability on Von kossa assay. The activities 
of MEPE suggest that, is most likely to be involved in the 
initiation of mineralization in dentine respectively. It is 
possible that MEPE may effectively stimulate DPSC 
proliferation in vivo and consequently, enhance the ability 
of injured pulp to survive trauma such as occurs in dental 
restorations. Further studies to determine the role of 
MEPE in odontoblast formation will allow us to use these 
proteins to develop tools to promote the regeneration of 
dental tissues. 
In summary, we cloned MEPE cDNA by RT-PCR from 
human cDNA library, expressed MEPE proteins in E.coli 
cells, purified the recombinant protein and then 
investigated the role of MEPE in dental pulp cells 
(DPSCs) ability of mineralization. Finally, it is propose 
that this protein is involved in the increasing of HA at the 
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